Leaflet NEOCRYSTEPIN 25mg / 0.5mg / 0.1mg sugar-coated tablets
Indicated for: hypertension
Route of administration: oral
Substance: chlorthalidone + dihydroergocrystine + reserpine (diuretic + antihypertensive)
ATC: C02LA51 (Cardiovascular system | Antihypertensives and diuretics in combination | Rauwolfia alkaloids and diuretics in combination)
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Periodic laboratory tests may be required during treatment.
This medicine may change blood electrolyte levels.
This combination of chlorthalidone, dihydroergocristine, and reserpine is used for the treatment of hypertension. Chlorthalidone is a thiazide diuretic that reduces blood volume, dihydroergocristine is an ergot derivative that improves circulation, and reserpine works by reducing sympathetic nervous system activity.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor blood pressure.
Patients should be aware of potential side effects, such as dizziness, fatigue, or dry mouth. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, fatigue, dry mouth, and nausea. In rare cases, severe reactions such as depression or electrolyte imbalances may occur. Patients should be informed of these risks before starting treatment.
General data about NEOCRYSTEPIN 25mg / 0.5mg / 0.1mg
- Substance: chlorthalidone + dihydroergocrystine + reserpine
- Date of latest medicines list: 01-07-2013
- Product code: W01805001
- Concentration: 25mg / 0.5mg / 0.1mg
- Pharmaceutical form: sugar-coated tablets
- Quantity: 30
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.